Biocerox Products BV develops monoclonal antibodies directed at an immune checkpoint modulator. The company is headquartered in Utrecht, the Netherlands.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence

Sichuan Jiuzhang Biotechnology Co., Ltd., established on 1999-04-27, Business scope includes drug research and development;chemical reagent(Free of Hazardous Chemicals)Research,Sales;Polymer Materials,biomaterials(Except for those prohibited by national laws and regulations and with special provisions)Research,Production,Sales;Sales:Chemical Products(Free of Hazardous Chemicals);Import and export,Technology Import and Export(National law,Except where prohibited by administrative regulations;law,Projects restricted by administrative regulations can only be operated after obtaining a license;The industrial industry involved in production establishes another branch or chooses another business site for operation);Sales of Jiuzhang Lutai Chewable Tablets(Operate within the validity period with the license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Shanghai Yaodan Biotechnology Co., Ltd., established on 2013-01-24, Business scope includes general items:Engaged in technology development in the field of biotechnology,technical consulting,Chemical product sales(No licensed chemical products).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Qichensheng Biotechnology (Zhuhai) Co., Ltd., established on 2018-08-30, The scope of business includes engaging in biomedicine,Development of biological detection and therapeutic technologies,production and sales,Technical Services,technical consulting,technology transfer,Technical Training;Sales of chemical products,chemical reagent,Instrumentation,Iclass of medical devices;Import and export of goods or technology;market survey,information service,Software development and sales,Information Security Services,System Integration and Installation;science communication,publication retail;Conference Services;Undertake exhibition and display activities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Western Medical Beauty Biotechnology Chengdu Co., Ltd. Shuangliu Medical Branch, established on 2021-04-19, Business scope includes licensed projects:medical service;Medical beauty service;Drug Wholesale;Drug retail;Class III medical device business;Drug Clinical Trial Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Health Consulting Services(Does not include medical services);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Human stem cell technology development and application.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Bioceros B.V. operates as a biopharmaceutical research and development contract organization. The company focuses on providing a range of technical and scientific expertise ranging from discovery research to pre-clinical development. Its services include assay development and quantification, pre-clinical development, molecular biology, cell biology and immunology, protein expression in various systems, upscaling/fermentation, protein purification, and consulting services. The company offers its services to other biotech companies, academic institutions, and pharmaceutical companies. Bioceros B.V. was founded in 2003 and is based in Utrecht, the Netherlands.

Guangzhou Anhao Pharmaceutical Technology Co., Ltd., established on 2014-05-14, Business scope includes drug research and development;Medical supplies and equipment retail(Does not contain drugs and medical devices);Health food wholesale(Specific business items are<food business license>prevail);Health Food Retail(Specific business items are<food business license>prevail);Wholesale Prepackaged Food;Prepackaged Food Retail